Education > XRAY > Breast Cancer

FORCE's eXaming the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

31 through 40 of 198

Relevance: High

pointerRelevance

Strength of Science: High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Women who exercise have lower breast cancer risk whether or not they have a family history of breast cancer

Most relevant for: Young, high risk women

The effect of physical activity on breast cancer risk was looked at  in a study of over 15,000 women. The results suggest that exercise lowers breast cancer risk regardless of family  history of breast cancer or menopausal status.  (12/6/19)

Este artículo está disponible en español.

Read More
Women who exercise have lower breast cancer risk whether or not they have a family history of breast cancer

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Human Research

pointerResearch Timeline
View Related Clinical Trials

Study : A new blood test may help predict early-stage breast cancer patients at highest risk for recurrence

Most relevant for: People with early-stage breast cancer

Which patients are at risk for a relapse of early-stage breast cancer? Tests to predict recurrence would help find people who need more monitoring after treatment and provide a chance to find and treat them earlier. This study looked at whether a blood test for tumor DNA (called circulating tumor DNA or ctDNA) is useful for finding people with recurrence earlier than current clinical practice. (11/4/19)

Este artículo está disponible en español.

Read More
A new blood test may help predict early-stage breast cancer patients at highest risk for recurrence

Relevance: Medium-Low

pointerRelevance

Research Timeline: Human Research

pointerResearch Timeline
View Related Clinical Trials

Personal Story : A “flu shot” against breast cancer? Not so fast

Most relevant for: Women diagnosed with Ductal Carcinoma In Situ (DCIS)

There have been multiple reports in the media of a Florida woman who had a "shot" to treat her DCIS with a promising outcome. This XRAY reviews the underlying story about this early breast cancer vaccine trial. (10/25/19)

Read More
A “flu shot” against breast cancer? Not so fast

Relevance: High

pointerRelevance

Quality of Writing: High

pointerQuality of Writing
View Related Clinical Trials

Personal Story : Running marathons with metastatic breast cancer? Yes!

Most relevant for: Women with metastatic breast cancer

Runner’s World Magazine featured Sarah Smith, a metastatic breast cancer patient who runs marathons and ultra-marathons. By telling her story, Sarah wants to encourage people to stay active, despite the challenges that life may bring. (10/13/19)

Read More
Running marathons with metastatic breast cancer? Yes!

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Human Research

pointerResearch Timeline
View Related Clinical Trials

Study : Research on the PARP inhibitor talazoparib (Talzenna) for early-stage breast cancer is promising

Most relevant for: People with early stage breast cancer who have an inherited BRCA mutation

The PARP inhibitor talazoparib (Talzenna) has been useful for treatment of advanced or metastatic breast cancer for patients with BRCA mutations. A preliminary study showed that the majority of patients who took talazoparib alone before surgery for early-stage breast cancer had effective treatment and manageable side effects. Expanded clinical trials are in progress to verify this result. (10/4/19)

Read More
Research on the PARP inhibitor talazoparib (Talzenna) for early-stage breast cancer is promising

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Inherited mutations in metastatic breast cancer patients

Most relevant for: People with metastatic breast cancer

Recent research shows that a significant portion of patients with metastatic breast cancer have harmful mutations in a gene associated with hereditary breast cancer and increased breast cancer risk. (9/26/19)

Read More
Inherited mutations in metastatic breast cancer patients

Relevance: Medium

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline

Guideline : FDA issues warning on CDK inhibitors

Most relevant for: People currently taking a CDK inhibitor

The U.S. Food and Drug Administration issued a safety alert for CDK inhibitors, including Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib). (9/24/19)

Read More
FDA issues warning on CDK inhibitors

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science
View Related Clinical Trials

Study : Does eating meat affect breast cancer risk?

Most relevant for: Women with a family history of breast cancer

Eating meat has been suggested to increase breast cancer risk. The recent Sister Study looked at meat type, cooking methods and breast cancer risk in a study of 42,012 women.  (9/10/19)

Read More
Does eating meat affect breast cancer risk?

Relevance: High

pointerRelevance

Strength of Science: High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Is it safe for BRCA mutation carriers to become pregnant following breast cancer?

Most relevant for: Women with a BRCA mutation who are considering pregnancy after breast cancer

New research shows that pregnancy after breast cancer is safe for women with BRCA mutations and their babies. (9/4/19)

Read More
Is it safe for BRCA mutation carriers to become pregnant following breast cancer?

Relevance: High

pointerRelevance

Strength of Science: Medium

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Supportive care can improve quality of life for people with metastatic breast cancer

Most relevant for: People diagnosed with metastatic breast cancer

Metastatic breast cancer patients have unique needs for treatment and care. Connecting patients to appropriate support services and palliative care is an area of need in health care. A recent study reported improvement in metastatic breast cancer patient quality of life and wellness with an intervention program called the Supportive, Education and Advocacy (MBC-SEA) program. (8/21/19)

Read More
Supportive care can improve quality of life for people with metastatic breast cancer

This Portal Sponsored By:

Centers for Disease Control